In a study assessed by Lebedev et al. in a population of T2DM patients, the results showed a strong prediction of heart failure, indicating higher levels of Gal-3 in patients with HFpEF and HFmEF compared to DM patients without HF [56]. This evidence concerns the gene LGALS3 and diabetes mellitus.